Credits: Canva
Quademic 2025: Hospitals in the United States are dealing with a surge in patients admission, the reason is the quademic it is dealing with at this moment. This has led to an influx of patients. It is all caused by seasonal infections, including common flu, Covid-19, and respiratory syncytial virus (RSV) that dominate the winter season in the US. This year, norovirus also joined the list, which has further increased the load on the healthcare.
The healthcare company founded in academics M Health Fairview, confirmed that their hospitals are overflowing due to the quademic.
The hospitals of M Health Fairview's volume is up by 30% and as a results, patients are being treated in the hallways and in alternative care areas. There is also a longer wait time and shortages for resources that are required to treat these emergencies. This has also impacted other life-threatening emergencies like heart attacks and strokes, as the healthcare resources and caregivers are occupied with the surge in seasonal cases.
ALSO READ: Birmingham Struggles With 4 Different Virus Hits, Know What They Are
Common cold and flu: The common cold and influenza (flu) are perhaps the most well-known illnesses that peak during the fall. As temperatures drop and humidity levels fluctuate, viruses that cause colds and the flu become more active. The flu, in particular, can be more severe than a common cold, leading to complications such as pneumonia, especially in vulnerable populations like the elderly and those with pre-existing health conditions. Symptoms include a runny nose, sore throat, coughing, fever, and body aches.
Covid-19: As per the World Health Organization, Coronavirus disease or COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with this virus will experience mild to moderate respiratory illness and recover without requiring special treatment, However, there could be some cases of seriously ill patients who may require medical attention. It is also because of the other existing medical conditions like cardiovascular diseases, diabetes, chronic respiratory diseases, cancers, or older age.
The best way to protect against this virus is by following social isolation form those who are infected, using mask to prevent droplets from infecting others when you cough or sneeze and to wash your hands for 20 seconds frequently.
RSV or Respiratory Syncytial Virus: As per the Centers of Diseases Control and Prevention (CDC), RSV is a common respiratory virus that infects nose, throat and lungs. Though symptoms are similar to the viruses like flu or COVID-19, the disease in itself is different. It also peaks during the winter season, especially between December and January.
However, the main difference between RSV and other respiratory illness, above mentioned is that RSV can cause pneumonia or bronchiolitis, especially for those who are over the age of 50 or with an existing heart or lung disease.
Norovirus: It is a number 1 cause of foodborne illness in the US and this happens when virus gets into the food and then it accidentally enters your mouth. These particles are from faeces or vomit from infected people, or can be transmitted via contaminated food and water. It could also spread by touching unclean surfaces like door handles or cutlery.
For most people, having norovirus is unpleasant, but mild and recovery could be made in 1 to 2 days. However, it could be more serious for babies, older people and anyone with any existing health condition.
Credit: AI
Small-cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer. It tends to grow rapidly, spread early and often returns even after initially responding well to treatment.
A new drug combination from Amgen and AstraZeneca has shown a significant overall survival benefit in patients with extensive-stage small-cell lung cancer (ES-SCLC), offering a new way to delay the disease's return and progression.
On September 8, the companies said that the Phase III DeLLphi-305 trial found that combining Amgen's tarlatamab, marketed as Imdelltra, with AstraZeneca's durvalumab, marketed as Imfinzi, significantly improved overall survival compared with Imfinzi alone.
The cancer can initially respond well to chemotherapy, but that response often does not last for a long time.
Many tumours become resistant to treatment, allowing the disease to return and become harder to treat. Research has described recurrent SCLC as frequently resistant to further therapy.
This is particularly challenging disease goes in extensive stage, where the cancer has already spread beyond the lung. Even with current treatments, the median overall survival for ES-SCLC remains around one year.
Also read: 25 Years After 9/11: What New Records Reveal About Toxic Air In New York
The two medicines attack the cancer through different mechanisms. Durvalumab is an immune checkpoint inhibitor. It blocks PD-L1, a protein cancers can use to evade the immune system, helping immune cells recognise and attack cancer cells.
Tarlatamab is a bispecific T-cell engager. It is designed to attach to DLL3 on small-cell lung cancer cells and CD3 on T cells, effectively bringing immune cells into contact with the cancer cells so they can destroy them. DLL3 is found on the surface of SCLC cells in about 85%-96% of patients but is minimally expressed on healthy cells.
In the trial, 563 patients whose disease had not progressed after initial treatment with Imfinzi plus platinum chemotherapy and etoposide were randomly assigned to receive either the combination or Imfinzi alone as maintenance treatment.
The combination improved overall survival, progression-free survival and response rate. No new safety concerns were identified.
The significance of the findings lies in effectively controlling the cancer after initial treatment, when the disease is at the highest risk of returning.
Jacob Sands, MD, Associate Chief of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, said: “Given the aggressive nature of small cell lung cancer, many patients quickly relapse on current therapy and never reach second-line treatment.” He added that the results suggest the potential to reshape the natural history of the disease.
Susan Galbraith, AstraZeneca's Executive Vice President of Oncology Haematology R&D, said the results showed an “unprecedented improvement in overall survival” for patients with this highly aggressive cancer.
The full trial data are yet to be presented at a medical meeting and will be submitted to regulatory authorities.
Credit: US CDC/Reuters
Toxic air persisted for months after the fatal 9/11 attacks on the World Trade Center, which killed more than 2,000 people, even as officials played down the health risks at Ground Zero in New York’s Manhattan, according to a trove of newly released files.
New York City Mayor Zohran Mamdani today released more than 170,000 documents from government agencies related to post-9/11 air quality and health risks. He accused officials of lying to the public about the dangers of toxic air at Ground Zero, where the World Trade Center towers collapsed in 2001.
“People got sick because the leaders they trusted lied and told them they were safe to breathe in toxic air,” Mamdani said at a news conference with survivors.
“As the years pass and the human toll grows, we reckon with the cost of September 11th whenever another New Yorker is stolen from us too soon. Now, close to 25 years later, more people have died from 9/11-related illnesses than were killed on the day itself.
“The very least our city owes the families, survivors and first responders whose lives were forever changed by the September 11th attacks is transparency and accountability. That is why I am proud that our administration has launched the City’s first public records portal dedicated to the environmental and health impacts of 9/11 and reached a settlement in these lawsuits,” said Mayor Mamdani.
The files, released Tuesday and made available through an online portal, include 68 boxes of documents that were discovered last year, the Harding Memo and records concerning World Trade Center 7.
The 68 boxes had not been located until 2025, despite multiple Freedom of Information Law (FOIL) requests.
One key document is the October 2001 “Harding Memo”, in which an aide warned former Deputy Mayor Robert Harding, who served under then-Mayor Rudy Giuliani, that the city could face as many as 35,000 legal claims over its response to the attacks.
The memo states that the city could face lawsuits because health advisories had caused individuals “to return to the area too soon (causing toxic exposure or emotional harm).”
“There was poison in the air and on the ground and in the window sills and in your air conditioners and covering your pets and your clothes, and it stayed there for months. Everyone knew. And now it's very clear that the city knew as well,” said advocate Jon Stewart, CBS News reported.

Days after the attacks, city and federal officials, including the US Environmental Protection Agency (EPA), declared that the air near the Twin Towers was safe. Subsequent research, however, found that people had been exposed to toxic chemicals.
Christine Todd Whitman, who headed the EPA at the time, later apologized for the declaration, saying the agency “did the very best we could at the time with the knowledge we had,” BBC reported.
In Lower Manhattan, the plane crashes and subsequent collapse of the Twin Towers created massive dust clouds that filled the air. Hundreds of highly populated city blocks were covered with ash, debris and harmful particles, including asbestos, silica, metals, concrete and glass.
According to the US CDC, fires within the debris pile and the collapse of 7 World Trade Center continued to burn through the end of December 2001, with flare-ups continuing into 2002. The fires released carcinogenic combustion by-products, while contaminants remained in Lower Manhattan and parts of Brooklyn for an undetermined period after 9/11.
Responders, local workers, residents, students and others faced potential exposure in the early days and in the months that followed. They could have been exposed to residual materials indoors and outdoors, as well as toxic gases, smoke, vapozrs and combustion by-products from continuing fires.
Credit: iStock
Manila is witnessing a sharp rise in leptospirosis cases, with infections now crossing the city’s epidemic threshold following widespread exposure to floodwaters in August.
Nearly 1,000 cases have been reported in Manila this year, with the number rising rapidly over the past two weeks, Manila City health officer Grace Padilla told ABS-CBN News.
Padilla said the city’s attack rate has reached three, signaling a high level of transmission in the affected population.
Health officials expect cases to continue rising as more residents who came into contact with floodwater in late August seek medical attention.
The surge in cases has also put additional pressure on hospitals across Manila. The city is also providing post-exposure prophylaxis at 44 health centers to people considered at risk following exposure to potentially contaminated floodwater, the report said.
The situation extends beyond Manila. Metro Manila has recorded at least 1,961 cases, with Manila and Quezon City reporting the highest cumulative numbers, followed by Caloocan and Taguig.
The outbreak is part of a wider national burden. From January 1 to August 29, the Philippines recorded 6,253 leptospirosis cases and 378 deaths, according to the health department’s epidemiology bureau.
Why Floodwater Raises Leptospirosis Risk
Leptospirosis is one of the most prevalent zoonotic diseases worldwide, often linked to poor sanitation and agricultural practices that involve contact with animals or contaminated water.
The bacteria can survive in contaminated water or soil for weeks to months, primarily spreading through the urine of infected animals. Humans can contract the disease through direct contact with infected urine or through contaminated food, water, or soil.
Flooding can increase the risk of exposure by spreading contaminated water through homes, streets and communities.
Symptoms typically develop 2 to 30 days after exposure and can range from mild to severe. Initial signs often include high-grade fever, red eyes (conjunctival suffusion), calf tenderness, headache, dry cough, nausea, and diarrhea.
In more serious cases, the infection can lead to complications such as jaundice, kidney or liver damage, meningitis, respiratory issues, and hemorrhages.
The health authorities in Manila shared that people who have recently been exposed to floodwater should watch for symptoms such as fever, headache, muscle pain and joint pain and seek medical attention if they develop them.
The infection can be treated with antibiotics, including doxycycline, when prescribed by a doctor.
According to the Centers for Disease Control and Prevention (CDC), it is essential to avoid wading through dirty rainwater, especially during the rainy season, and to wear gumboots in such conditions.
Proper care of any injuries or cuts is crucial, and frequent handwashing, particularly after handling food or working in potentially contaminated environments, is highly recommended. Additionally, individuals should avoid contact with animals that appear sick or are known carriers of the bacteria.
© $2026 Times Horizon Private Limited